Status:
COMPLETED
Sphenopalatine Ganglion Block for Management of Post- Dural Puncture Headache in Obstetric Patients
Lead Sponsor:
Ain Shams University
Conditions:
Post-Dural Puncture Headache
Eligibility:
FEMALE
21-45 years
Phase:
NA
Brief Summary
The purpose of this trial is to study the efficacy and efficiency of sphenopalatine ganglion block for management of post dural puncture headache in obstetric patients
Detailed Description
Background and objectives: Post dural puncture headache(PDPH) is a common complication of lumbar puncture, it is likely due to the loss of cerebrospinal fluid into the epidural space through the dural...
Eligibility Criteria
Inclusion
- Female patients ASA I or II post caesarean section
- Body weight between 60-100 kg
- Active PDPH within days after spinal anesthesia not relieved with standard treatment such as, intravenous fluids, bed rest and caffeine.
Exclusion
- Patient refusal to participate in the study
- Body mass index \>35kg/m2
- Patients with :coagulopathy ,nasal septal deviation,polyp
- History of nasal bleeding
- Allergy to local anesthetic
Key Trial Info
Start Date :
March 15 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 5 2021
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04793490
Start Date
March 15 2021
End Date
December 5 2021
Last Update
February 16 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ain Shams University Hospital
Cairo, Abassia, Egypt, 11591